isocarboxazid has been researched along with Schizophrenia in 17 studies
Isocarboxazid: An MAO inhibitor that is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in the treatment of panic disorder and the phobic disorders. (From AMA, Drug Evaluations Annual, 1994, p311)
Schizophrenia: A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior.
Excerpt | Relevance | Reference |
---|---|---|
"To determine whether the use or the withdrawal of anticholinergic drugs (benzhexol, benztropine, biperiden, orphenadrine, procyclidine, scopolamine, or trihexylphenidyl) are clinically effective for the treatment of people with both antipsychotic-induced tardive dyskinesia and schizophrenia or other chronic mental illnesses." | 4.98 | Anticholinergic medication for antipsychotic-induced tardive dyskinesia. ( Bergman, H; Soares-Weiser, K, 2018) |
" By measuring the brain function using computer period analysis of cerebral biopotentials, dose-efficacy relations were found (in the range of 25-75 mcg) which suggest the bioavailability of LHM at the CNS level." | 2.64 | Prediction of psychotropic properties of lisuride hydrogen maleate by quantitative pharmaco-electroencephalogram. ( Akpinar, S; Herrmann, WM; Itil, TM, 1975) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 16 (94.12) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (5.88) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bergman, H | 1 |
Soares-Weiser, K | 1 |
CASEY, JF | 1 |
HOLLISTER, LE | 1 |
KLETT, CJ | 1 |
LASKY, JJ | 1 |
CAFFEY, EM | 1 |
DARLING, HF | 1 |
SCHIELE, BC | 1 |
BRUNE, GG | 1 |
HOHL, HH | 1 |
HIMWICH, HE | 1 |
GREENBLATT, M | 2 |
GROSSER, GH | 1 |
WECHSLER, H | 1 |
HANKOFF, LD | 1 |
GUNDLACH, RH | 1 |
PALEY, HM | 1 |
RUDORFER, L | 1 |
PARK, LC | 1 |
BALDESSARINI, RJ | 1 |
KETY, SS | 1 |
DESTOUNIS, N | 1 |
PINTO, A | 1 |
JOHNSON, C | 1 |
COOPER, M | 1 |
Kakimoto, Y | 1 |
Sano, I | 1 |
Kanazawa, A | 1 |
Tsujio, T | 1 |
Kaneko, Z | 1 |
Itil, TM | 1 |
Herrmann, WM | 1 |
Akpinar, S | 1 |
Youdim, MB | 1 |
Lipman, RS | 1 |
Uhlenhuth, EH | 1 |
Rickels, K | 1 |
Covi, L | 1 |
Bucci, L | 1 |
Feldstein, A | 1 |
Hoagland, H | 1 |
Rivera Oktem, M | 1 |
Freeman, H | 1 |
Baronov, VF | 1 |
Kogan, RD | 1 |
Khrekov, PA | 1 |
3 reviews available for isocarboxazid and Schizophrenia
Article | Year |
---|---|
Anticholinergic medication for antipsychotic-induced tardive dyskinesia.
Topics: Antipsychotic Agents; Biperiden; Cholinergic Antagonists; Dyskinesia, Drug-Induced; Humans; Isocarbo | 2018 |
Efficacy of ECT in affective and schizophrenic illness.
Topics: Amitriptyline; Chlorpromazine; Depression; Electroconvulsive Therapy; Evaluation Studies as Topic; H | 1977 |
Monoamine oxidase. Its inhibition.
Topics: Bipolar Disorder; Brain; Clorgyline; Depression; Humans; Isocarboxazid; Mitochondria; Monoamine Oxid | 1975 |
4 trials available for isocarboxazid and Schizophrenia
Article | Year |
---|---|
Prediction of psychotropic properties of lisuride hydrogen maleate by quantitative pharmaco-electroencephalogram.
Topics: Adolescent; Adult; Aged; Biological Availability; Child; Child, Preschool; Clinical Trials as Topic; | 1975 |
Medication attitudes and drug response.
Topics: Anorexia Nervosa; Anxiety; Atropine; Attitude; Attitude of Health Personnel; Clinical Trials as Topi | 1969 |
The dyskenesias: a new therapeutic approach.
Topics: Chlorpromazine; Clinical Trials as Topic; Female; Humans; Isocarboxazid; Male; Middle Aged; Monoamin | 1971 |
MAO inhibition and antidepressant activity.
Topics: Adult; Antidepressive Agents; Bipolar Disorder; Clinical Trials as Topic; Depression; Humans; Isocar | 1965 |
10 other studies available for isocarboxazid and Schizophrenia
Article | Year |
---|---|
Combined drug therapy of chronic schizophrenics. Controlled evaluation of placebo, dextro-amphetamine, imipiramine, isocarboxazid and trifluoperazine added to maintenance doses of chlorpromazine.
Topics: Chlorpromazine; Dextroamphetamine; Drug Therapy, Combination; Isocarboxazid; Psychopharmacology; Sch | 1961 |
Isocarboxazid (marplan) in ambulatory psychiatric patients.
Topics: Depression; Depressive Disorder; Hydrazines; Isocarboxazid; Patients; Schizophrenia | 1959 |
Antidepressants: comparison of clinical effects in anergic schizophrenia and the depressed states.
Topics: Antidepressive Agents; Depression; Imipramine; Iproniazid; Isocarboxazid; Monoamine Oxidase Inhibito | 1963 |
URINARY EXCRETION OF BUFOTENIN-LIKE SUBSTANCE IN PSYCHOTIC PATIENTS.
Topics: 1-Propanol; Acetates; Alcohols; Alkaloids; Ammonia; Bufotenin; Chromatography; Hallucinogens; Humans | 1963 |
DIFFERENTIAL RESPONSE OF HOSPITALIZED DEPRESSED PATIENTS TO SOMATIC THERAPY.
Topics: Bipolar Disorder; Depression; Depressive Disorder; Depressive Disorder, Major; Electroconvulsive The | 1964 |
DIPHENHYDRAMINE AS AN ANTIDEPRESSANT: A NEGATIVE FINDING.
Topics: Antidepressive Agents; Biomedical Research; Bipolar Disorder; Depressive Disorder, Major; Diphenhydr | 1964 |
METHIONINE EFFECTS ON CHRONIC SCHIZOPHRENICS: PATIENTS TREATED WITH MONOAMINE OXIDASE INHIBITORS.
Topics: Biomedical Research; Drug Synergism; Drug Therapy; Glycine; Iproniazid; Isocarboxazid; Mental Disord | 1965 |
CLINICAL TRIAL OF ISOCARBOXAZID.
Topics: Biomedical Research; Depression; Depressive Disorder; Drug Therapy; Isocarboxazid; Mental Disorders; | 1965 |
Metabolic effects of methionine in schizophrenic patients pretreated with a monoamine oxidase inhibitor.
Topics: Adult; Amines; Catechols; Epinephrine; Female; Humans; Isocarboxazid; Methionine; Methylation; Middl | 1967 |
[On various combined methods of treatment of schizophrenic patients resistant to aminazine].
Topics: Adult; Blood Transfusion; Chlorpromazine; Hallucinations; Humans; Isocarboxazid; Middle Aged; Parano | 1967 |